Similar articles for PMID: 19783829

Year	Number of Results
1999	1
2000	1
2003	1
2004	2
2005	4
2006	8
2007	5
2008	12
2009	16
2010	12
2011	17
2012	13
2013	6
2014	9
2015	4
2016	11
2017	7
2018	4
2019	3
2020	2
2021	2
2022	2
2023	1
2024	0

1

Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.

Nam H, Chung BC, Kim Y, Lee K, Lee D. Nam H, et al. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25. Bioinformatics. 2009. PMID: 19783829

2

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P. Ou K, et al. J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5. J Proteome Res. 2008. PMID: 18318472

3

RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.

Chen Y, Zhang R, Song Y, He J, Sun J, Bai J, An Z, Dong L, Zhan Q, Abliz Z. Chen Y, et al. Analyst. 2009 Oct;134(10):2003-11. doi: 10.1039/b907243h. Epub 2009 Aug 14. Analyst. 2009. PMID: 19768207

4

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A. Rody A, et al. Zentralbl Gynakol. 2006 Apr;128(2):76-81. doi: 10.1055/s-2006-921508. Zentralbl Gynakol. 2006. PMID: 16673249 Clinical Trial.

5

Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.

Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, Wang Q, Shen X. Wu H, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3111-7. doi: 10.1016/j.jchromb.2009.07.039. Epub 2009 Aug 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19716777

6

Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics.

Nagaraja GM, Othman M, Fox BP, Alsaber R, Pellegrino CM, Zeng Y, Khanna R, Tamburini P, Swaroop A, Kandpal RP. Nagaraja GM, et al. Oncogene. 2006 Apr 13;25(16):2328-38. doi: 10.1038/sj.onc.1209265. Oncogene. 2006. PMID: 16314837

7

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH. Gast MC, et al. Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082706 Review.

8

Robust and efficient identification of biomarkers by classifying features on graphs.

Hwang T, Sicotte H, Tian Z, Wu B, Kocher JP, Wigle DA, Kumar V, Kuang R. Hwang T, et al. Bioinformatics. 2008 Sep 15;24(18):2023-9. doi: 10.1093/bioinformatics/btn383. Epub 2008 Jul 24. Bioinformatics. 2008. PMID: 18653521

9

Identification of Cystatin SN as a novel tumor marker for colorectal cancer.

Yoneda K, Iida H, Endo H, Hosono K, Akiyama T, Takahashi H, Inamori M, Abe Y, Yoneda M, Fujita K, Kato S, Nozaki Y, Ichikawa Y, Uozaki H, Fukayama M, Shimamura T, Kodama T, Aburatani H, Miyazawa C, Ishii K, Hosomi N, Sagara M, Takahashi M, Ike H, Saito H, Kusakabe A, Nakajima A. Yoneda K, et al. Int J Oncol. 2009 Jul;35(1):33-40. Int J Oncol. 2009. PMID: 19513549

10

Biomarkers in breast cancer.

Vivanco Md. Vivanco Md. Methods Mol Biol. 2010;593:137-56. doi: 10.1007/978-1-60327-194-3_7. Methods Mol Biol. 2010. PMID: 19957148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

127 results

Results by year